Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma CaSki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways

Proteomics

Volumn 13, Issue 23-24, 2013, Pages 3411-3423

  Pan, Tai Long ^a   Wang, Pei Wen ^a   Hung, Yu Chiang ^b   Huang, Chun Hsun ^c   Rau, Kun Ming ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Apoptosis; Cell biology; Cervix cancer; Reticulum stress; Tanshinone IIA

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE; PACLITAXEL; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TANSHINONE IIA;

ADULT; ADVANCED CANCER; AGED; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; IC 50; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

APOPTOSIS; CELL BIOLOGY; CERVIX CANCER; RETICULUM STRESS; TANSHINONE IIA;

ADULT; AGED; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DITERPENES, ABIETANE; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MIDDLE AGED; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PACLITAXEL; PROTEOME; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84890298665     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300274     Document Type: Article

References (41)

1. de Freitas, A. C., Gurgel, A. P., Chagas, B. S., Coimbra, E. C. et al., Susceptibility to cervical cancer: an overview. Gynecol. Oncol. 2012, 126, 304-311.
2. Franco, E. L., Harper, D. M., Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 2005, 23, 2388-2394.
3. Luo, T., Yu, J., Nguyen, J., Wang, C. R. et al., Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers. Proc. Natl. Acad. Sci. USA 2012, 109, 10175-10180.
4. Faried, L. S., Faried, A., Kanuma, T., Nakazato, T. et al., Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. Eur. J. Cancer 2006, 42, 934-947.
5. Sun, Y., Liu, J. H., Jin, L., Lin, S. M. et al, Over-expression of the Beclin1 gene upregulates chemosensitivity to anti-cancer drugs by enhancing therapy-induced apoptosis in cervix squamous carcinoma CaSki cells. Cancer Lett. 2010, 294, 204-210.
6. Wang, X., Morris-Natschke, S. L., Lee, K. H., New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med. Res. Rev. 2007, 27, 133-148.
7. Zhang, Y., Wei, R. X., Zhu, X. B., Cai, L. et al., Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro. Anticancer Drugs 2012, 23, 212-219.
8. Zhen, X., Cen, J., Li, Y. M., Yan, F. et al., Cytotoxic effect and apoptotic mechanism of tanshinone A, a novel tanshinone derivative, on human erythroleukemic K562 cells. Eur. J. Pharmacol. 2011, 667, 129-135.
9. Pan, T. L., Hung, Y. C., Wang, P. W., Chen, S. T. et al., Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells. Proteomics 2010, 10, 914-929.
10. Hartman, M. L., Czyz, M., Anti-apoptotic proteins on guard of melanoma cell survival. Cancer Lett. 2013, 331, 24-34.
11. Ashkenazi, A., Holland, P., Eckhardt, S. G., Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J. Clin. Oncol. 2008, 26, 3621-3630.
12. Hockenbery, D. M., Targeting mitochondria for cancer therapy. Environ. Mol. Mutagen. 2010, 51, 476-489.
13. Wali, V. B., Bachawal, S. V., Sylvester, P. W., Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells. Apoptosis 2009, 14, 1366-1377.
14. Hetz, C., The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell. Biol. 2012, 13, 89-102.
15. Tabas, I., Ron, D., Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell. Biol. 2011, 13, 184-190.
16. Pan, T. L., Wang, P. W., Leu, Y. L., Wu, T. H. et el., Inhibitory effects of Scutellaria baicalensis extract on hepatic stellate cells through inducing G2/M cell cycle arrest and activating ERK-dependent apoptosis via Bax and caspase pathway. J. Ethnopharmacol. 2012, 139, 829-837.
17. Pan, T. L., Wang, P. W., Explore the molecular mechanism of apoptosis induced by tanshinone IIA on activated rat hepatic stellate cells. Evid. Based Complement. Alternat. Med. 2012, 734987, 1-15.
18. Pan, T. L., Wang, P. W., Chen, C. C., Fang, J. Y. et al., Functional proteomics reveals hepatotoxicity and the molecular mechanisms of different forms of chromium delivered by skin administration. Proteomics 2012, 12, 477-489.
19. Pan, T. L., Wang, P. W., Huang, C. C., Yeh, C. T. et al., Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells. J. Proteomics 2012, 75, 4676-4692.
20. Pan, T. L., Wang, P. W., Chen, S. T., Fang, J. Y. et al., Prospective highlights of serum glycoproteins in spontaneous tolerance after orthotopic liver transplantation. Clin. Chim. Acta. 2011, 412, 604-613.
21. Leath, C. A. III, Straughn, J. M., Jr., Chemotherapy for advanced and recurrent cervical carcinoma: results from cooperative group trials. Gynecol. Oncol. 2013, 129, 251-257.
22. Wang, B., Rosano, J. M., Cheheltani, R., Achary, M. P. et al., Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer. Expert. Opin. Drug Deliv. 2010, 7, 1159-1173.
23. Drayton, R. M., Catto, J. W., Molecular mechanisms of cisplatin resistance in bladder cancer. Expert. Rev. Anticancer Ther. 2012, 12, 271-281.
24. Murray, S., Briasoulis, E., Linardou, H., Bafaloukos, D. et al., Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat. Rev. 2012, 38, 890-903.
25. McGrogan, B. T., Gilmartin, B., Carney, D. N., McCann, A., Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta. 2008, 1785, 96-132.
26. Su, C. C., Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp. Ther. Med. 2012, 3, 555-559.
27. Kulikov, A.V., Shilov, E. S., Mufazalov, I. A., Gogvadze, V. et al., Cytochrome c: the Achilles' heel in apoptosis. Cell. Mol. Life Sci. 2012, 69, 1787-1797.
28. Chen, F., JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012, 72, 379-386.
29. Kriegenburg, F., Poulsen, E. G., Koch, A., Krüger, E. et al., Redox control of the ubiquitin-proteasome system: from molecular mechanisms to functional significance. Antioxid. Redox. Signal. 2011, 15, 2265-2299.
30. Gregersen, N., Bross, P., Protein misfolding and cellular stress: an overview. Methods Mol. Biol. 2010, 648, 3-23.
31. Gorman, A. M., Healy, S. J., Jäger, R., Samali, A., Stress management at the ER: regulators of ER stress-induced apoptosis. Pharmacol. Ther. 2012, 134, 306-316.
32. Santos, C. X., Tanaka, L. Y., Wosniak, J., Laurindo, F. R., Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 2009, 11, 2409-2427.
33. Ni, M., Zhang, Y., Lee, A. S., Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem. J. 2011, 434, 181-188.
34. Yamagishi, N., Ueda, T., Mori, A., Saito, Y. et al., Decreased expression of endoplasmic reticulum chaperone GRP78 in liver of diabetic mice. Biochem. Biophys. Res. Commun. 2012, 417, 364-370.
35. Zhang, D., Richardson, D. R., Endoplasmic reticulum protein 29 (ERp29): an emerging role in cancer. Int. J. Biochem. Cell. Biol. 2011, 43, 33-36.
36. Zanini, C., Pulera, F., Carta, F., Giribaldi, G. et al., Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing's sarcoma. Virchows Arch. 2008, 452, 157-167.
37. Noguchi, T., Ishii, K., Fukutomi, H., Naguro, I. et al., Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J. Biol. Chem. 2008, 283, 7657-7665.
38. He, Y., Beatty, A., Han, X., Ji, Y. et al., Nonmuscle myosin IIB links cytoskeleton to IRE1α signaling during ER stress. Dev. Cell. 2012, 23, 1141-1152.
39. Goldmann, W. H., Auernheimer, V., Thievessen, I., Fabry, B., Vinculin, cell mechanics and tumour cell invasion. Cell Biol. Int. 2013, 37, 397-405.
40. Loureiro, S. O., Heimfarth, L., Reis, K., Wild, L. et al., Acute ethanol exposure disrupts actin cytoskeleton and generates reactive oxygen species in c6 cells. Toxicol. In Vitro 2011, 25, 28-36.
41. Nelson, E. S., Folkmann, A. W., Henry, M. D., DeMali, K. A., Vinculin activators target integrins from within the cell to increase melanoma sensitivity to chemotherapy. Mol. Cancer Res. 2011, 9, 712-723.